Home > Insider Trading > Filing (0001387131-21-005567)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
25743	Therapeuticsmd Inc.	TXMD	Pharmaceutical Preparations (2834)	870233535

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1532230	Iv C.k. John Milligan	951 Yamato Road, Suite 220 Boca Raton FL 33431	Secretary/Ceo Of Subsidiary	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-05-10	103,500	$0.00	1,796,955	No	4	M	Direct
Common Stock	Disposition	2021-05-11	44,252	$1.04	1,752,703	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2021-05-10	103,500	$0.00	103,500	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
207,000			No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,582,373	Indirect	See Footnote

Footnotes

On May 10, 2021, the reporting person received 103,500 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.
The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
Shares are owned by John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended.
Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.